GlaxoSmithKlineThe Impact of Medicines: Sustainability in Environment, Health and Safety Report 2002
Reporting Front PageDownloads
EHS 2002 home

About this report

About GSK

Report scope

Executive statements

Framework

Issues

Performance

Verification statement

Index

About this report
Previous
Next
 
 

Welcome to Sustainability in Environment, Health and Safety 2002, the GlaxoSmithKline review of environment, health and safety programmes and performance for 2002. It is a companion to The Impact of Medicines, Corporate and Social Responsibility Report 2002 and provides additional information about our EHS programmes and details of our EHS performance and progress to targets.

By publishing the EHS report on the web, we can include detailed information that has been requested by some of our reviewers. We can also link information within the report to make it easier to read just what each individual reader wants to see. Although some of the information about our Framework and programmes has not changed from last year, we have included it within this report and the download file to facilitate complete understanding of our EHS performance without having to refer to previous reports.

This report is aimed at several audiences. For our external stakeholders it outlines how we manage our EHS risks and presents our EHS performance. For our internal stakeholders, our employees and managers, it provides a broad overview of how we manage EHS and the progress we have made as a result of their contributions.

Global Reporting Initiative

We have referred to the Global Reporting Initiative Sustainability Reporting Guidelines, published in 2002, in setting the content of this report, although the report covers only the EHS aspects of sustainability.

GRI iconWhere the GRI icon appears in this report, click to view a reference to related GRI sections. These references are also summarised in the GRI index.


Previous

Next


Top


EHS 2002 Home | Reporting Front Page | Downloads | Main Site

 
Updated July 21, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement